CVS Health Corporation is a good fit for Warren Buffett's 10x Pretax Rule. Under this rule, paying 10x pretax earnings is already a good deal for a business even if it stagnates forever (as long as...

Shares of CVS Health Corporation NYSE: CVS have been enjoying a decent run this month, with a 10% gain in less than two weeks. It comes after multiple months of consolidation and sideways trading, ...

With the equities sector falling flat while the cryptocurrency arena skyrockets, the difficulties associated with planning next moves help drive the bullish case for dividend-paying healthcare stoc...

CVS Health Corp (NYSE:CVS) has the unique opportunity as a health plan to leverage its high net promoter score retail franchise, according to BofA Securities analysts.  In an update to clients, the...

Here's today's Final Trades from the Investment Committee.

CVS held its investor day yesterday and Wall Street came away bullish. The healthcare giant will revamp the way it prices prescriptions, which could attract more business.

Jeff Jonas, Gabelli Funds Portfolio Manager, joins 'Closing Bell Overtime' to talk CVS overhauling drug pricing, investing opportunity in the healthcare sector and more.

Among the more stable stocks that have been more volatile than usual this year, CVS Health (NYSE: CVS ) is clearly seeing this volatility play out again today. Shares of CVS stock surged 4% in afte...

CVS Health (CVS) shares jumped about 4% Tuesday after the drugstore chain and health-care firm posted strong guidance and raised its dividend on reported higher demand for its health-care services.

Karen Lynch, CVS Health CEO, and CNBC's Bertha Coombs join 'The Exchange' to discuss the company's investor day, prescription drug pricing, and more.

Dr. Scott Gottlieb, former FDA commissioner, joins 'The Exchange' to discuss CVS Health's drug pricing, the role of AI in medicine, and more.

Pharmacy giant CVS Health on Tuesday announced an overhaul of its drug-pricing model to boost transparency amid scrutiny of the soaring cost for medications.

CVS's new effort aims to do away with a complex model that typically determines how much pharmacies get reimbursed and how much patients pay for medications.

Drugstore chain CVS guided fiscal 2024 revenue higher than expected, and raised the quarterly dividend by 10%.

CVS Health Inc.'s stock CVS, rose 3% premarket Tuesday, after the drug-store chain backed guidance for 2023 and set guidance for 2024 with revenue that's comfortably above consensus. The company sa...